Shield Therapeutics update on U.S. Commercialisation and John Meyer on 5 Resource Stocks
Episode 2195, Dec 10, 2020, 01:18 PM
Shield Therapeutics provides an update on its plans to commercialise Accrufer® in the USA. John Meyer talks about: Altus Strategies, Arc Minerals, Empire Metals, Rio Tinto & Solgold
On the Vox Markets Podcast Today: 10th December 2020
Tim Watts, CEO of Shield Therapeutics #STX provides an update on its plans to commercialise Accrufer® in the USA and talks about their cash position.
John Meyer, Mining analyst and partner at SP Angel talks about: Altus Strategies #ALS Arc Minerals #ARCM Empire Metals #EEE Rio Tinto #RIO & Solgold #SOLG
(Interview starts at 12 minutes 43 seconds)
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast